Tracking the Coronavirus Covid-19 Vaccines, Doses, Distribution and Vaccination Efforts Worldwide
We will surely end this Pandemic and “all be assured, the sun will shine on us again”.
The Human Race for Covid-19 Vaccine :
Total Coronavirus Vaccinated people in all countries, early approved and all trail vaccinated are more than 400,000.
Worldwide Coronavirus Cases: 157,561,279 Deaths: 3,284,409 Recovered: 135,861,913
Last updated: May 08, 2021, 07:22 UTC+00:00
The Race for Covid-19 Vaccination at unprecedented speed - till now and continues in 2021, Coronavirus vaccine worldwide efforts to back live normal. Coronavirus Vaccination static with progress as.
|Countries||Total Till Date||Estimated Vaccination in 2021||People Vaccinated / 100 people||Covid-19 Total Tests 5||Covid-19 Tests/1M pop 5||Population 2020 Estimated 6|
|United Arab Emirates||12,900,238||1,384,656||129.59||22,956,796||2,306,142||9,954,633|
Note: Total People Vaccination by end of 2021 as of COVID-19 vaccine pre-purchases by all countries source.
Vaccination This month, as Announced by their Government and local authorities projection. Some vaccines required the two-shot (2 doses) as count 1 vaccination, others vaccines candidate only 1 dose.
United Kingdom: NHS Efforts for 5 million Doses by end of year 2020 will Vaccinate 2.5 million people in the UK.
Canada: 96,000 Doses will vaccinate 48000 people in Canada this year.
US: 20 million Doses by end of year 2020 will Vaccinate 10 million people in the US.
We try to keep updated with all the data according to the latest news. Please check reference
World Covid-19 Vaccinated Progress: Past, Present and Future : Weekly Vaccinated
COVID-19 vaccine pre-purchases across the world
More than 200 COVID-19 vaccine candidates are in race to complete clinical trials at unprecedented speed; more than ten Covid-19 Vaccine are already in Phase 3 large-scale trials and few have received emergency authorization to use. Few rich countries purchased in (pre-order) more than enough doses for their population, even multiple times higher as Canada has purchased 5 times over to vaccinate its population. An estimate of Total vaccine DOSES 9.8 BILLION ARE ALREADY pre-order by countries governments.
Oxford University (AZD1222)
Novavax (NVX-Co V2373)
Sanofi-GSK (NVX-CoV-2 Vaccine)
Janssen (J&J) (Ad26.COV2.S)
G42 Healthcare (BBIBP-CorV)
CanSino Biologics (Ad5-nCoV)
Sinopharm (China N. P. G.)
COVAXX (U. B.) (UB-162)
Fosum Pharma (BNT-162)
|Latin America w/o Brazil||150M||150M|
The Pfizer-BioNTech COVID vaccine after getting approval US FDA for public use, it got high ratting as 6 countries approved it. List of countries which have approved Pfizer-BioNTech COVID vaccine in order get approval.
- United Kingdom - December 2
- Bahrain - December 5
- Canada -December 9
- Saudi Arabia - December 10
- Mexico - on December 11
- United States - December 12
- Israel - will be before December 27
List of countries who Approved ( Emergency Authorisation) or Full Authorisation
|Covid vaccine companies||Limited Approved ( Emergency Authorisation)||Approved Full Authorisation|
|BioNTech, Pfizer, Fosun Pharma Tozinameran||UK
|Gam-COVID-Vac (Sputnik V)||
|Moderna, NIAID, BARDA -mRNA-1273||US
|University of Oxford, AstraZeneca||Switzerland: Swissmedic|
|Ad5-nCoV CanSino Biologics||China|
Who will make the Vaccine to defeat the COVID-19?
Whenever humanity faces a disaster, calamity, and any misery they work together to defeat all the weaknesses. Generally, whenever there is some novel virus, disease, bacteria, and malnutritional problems the pharmaceutical, biotech companies, public health and university labs used to work in tandem to devise the possible solutions. Here are leading COVID-19 Vaccine Candidates their Progress on trial of Phase 1, Phase 2, Phase 3 and approved for limited use.
Leading Vaccine Candidates for COVID-19
Approved for limited use
|Vaccines||Phase 1 (Trial Start)||Phase 2||Phase 3 (Trial size)
Trial End date
|Sept 15, 2020||40,000
2 2-8° C 86%
|July 01, 2020||50,000
Dec 07, 2020
Aug 28, 2020
2 2-8° C 86%
2 2-8° C
|July 21, 2020||26,000
Anhui Zhifei Longcom
IMB at CAMB
Johnson & Johnson
1 2-8° C
|Sept 07, 2020||60,000
2 2-8° C 95%
|July 27, 2020||30,000
2 2-8° C 95%
|Sept 28, 2020||45,000
2 -18° C 91%
|Sept 07, 2020||40,000
Dec 01, 2020
Aug 11, 2020
2 -70° C 95%
|April 29, 2020||44,000
2 2-8° C 70%
|Aug 28, 2020||65,000
Mapping covid-19 vaccine pre-order worldwide, current supply predicts that we will not be having enough vaccines for all populations until 2023 or 2024. High-income countries are capable of pre-purchase while low-income countries are depending on the covax, which aims for two billion doses by the end of 2021.
Note: Map only shows publicly disclosed of covid-19 vaccine for countries with latest population data. Some countries not included in it are China, Russia.
|Countries||Vaccine Pre-Order Doses||No. of Vaccination Does||Covered Eligible People as % of Pop||Eligible population for Vaccination (above 16 years old) (Millions)||Population 2020 Estimated (Millions)|
|United States of America||1,010,000,000||605,000,000||261.11%||231.7019||331.0027|
|Papua New Guinea||1,252,583||1,252,583||20.00%||6.2629||8.9470|
|Northern Mariana Islands||8,058||8,058||20.00%||0.0403||0.0576|
|Trinidad and Tobago||195,928||195,928||20.00%||0.9796||1.3995|
|Turks and Caicos Islands||5,420||5,420||20.00%||0.0271||0.0387|
|United Arab Emirates||1,384,656||1,384,656||20.00%||6.9233||9.8904|
|US Virgin Islands||14,619||14,620||20.00%||0.0731||0.1044|
|Vatican City (Holy See)||112||112||20.00%||0.0006||0.0008|
|Wallis and Futuna||1,573||1,573||20.00%||0.0079||0.0112|
|Saint Helena, Ascension and Tristan da Cunha||850||851||20.00%||0.0043||0.0061|
|Saint Kitts and Nevis||7,447||7,448||20.00%||0.0372||0.0532|
|Saint Pierre and Miquelon||811||811||20.00%||0.0041||0.0058|
|Saint Vincent and the Grenadines||15,531||15,532||20.00%||0.0777||0.1109|
|Sao Tome and Principe||30,682||30,682||20.00%||0.1534||0.2192|
|Central African Republic||676,167||676,167||20.00%||3.3808||4.8298|
|Congo, Democratic Republic of the||12,538,596||12,538,596||20.00%||62.6930||89.5614|
|Micronesia, Federated States of||16,103||16,103||20.00%||0.0805||0.1150|
|Antigua and Barbuda||13,710||13,710||20.00%||0.0686||0.0979|
|Bosnia and Herzegovina||459,314||459,315||20.00%||2.2966||3.2808|
|British Virgin Islands||4,232||4,232||20.00%||0.0212||0.0302|
|Falkland Islands (Islas Malvinas)||487||487||20.00%||0.0024||0.0035|
|Macedonia, Republic of||291,672||291,672||20.00%||1.4584||2.0834|
|Korea, Democratic Republic of (North)||3,609,034||3,609,034||20.00%||18.0452||25.7788|
|Korea, Republic of (South)||7,177,685||7,177,686||20.00%||35.8884||51.2692|
|Isle of Man||11,904||11,905||20.00%||0.0595||0.0850|
COVAX AMC: As of 19 Dec, 2 Billion donor-funded vaccines by mind 2021 to the 92 low- and middle-income economies eligible countries which cover up to 20% population by the end of the year.
Who will get the vaccine first?
There are certain chances that the paramedics and healthcare staff will get the vaccine first. The safety of the experts, scientists, doctors and researchers is a top priority to accelerate the wave of safety towards the mass population of the whole world and specific countries.
The people of the country in which the vaccine will be manufactured will be served first. Dr. Anthony Fauci, the top US infectious disease expert said that we will certainly be able to produce vaccines at the start of 2021.
But after the vaccine, the greatest problem will be the distribution to the most needed people. For this US official announced to make a tiered system to export the vaccine to the most affected people from the COVID-19.
AstraZeneca has agreed to send 1 billion vaccine dosage in cooperation with India's Serum Institute.
The vaccine struggle in parallel is at a peak in Beijing, Britain and the US, to ensure the availability of the abundant amount of COVID-19 vaccine.
The players of the COVID-19 vaccine are myriads and they are spending millions of dollars to produce effective and workable vaccines to cure the maximum patient's in the least amount of time.
- International Institutions
- Private sector
- Research institutions and nonprofit organizations
The public health organization always has played a major role in the manufacturing of vaccines. The administration of the United States has launched a project named operation Warp Speed which is aimed to develop a highly effective vaccine at the start of 2021 for its 300 million US citizens.
This operation is promising to spend billions of dollars and is gathering a community of researchers from the national institute of health (NIH), the food and drug administration (FDA), the department of health and human services (NHS), the department of defense and world health organization.
On the same page, the Chinese government is funding and building infrastructure to provide as many facilities to study and manufacture the vaccine as possible. The European Commission is funding several candidates to find the vaccine in the shortest time possible. In a virtual summit attended by the world leaders, organizations and European leaders, the banks show their commitment to spend at least $8 billion for the research on the vaccine.
The international institution is acting as a central role in the production of the COVID-19 vaccine, its fair and easy distribution to billions of people across the globe and its authentic trial testing to analyze its effectiveness before its usage.
The world health organization and other international platforms such as the world bank are providing financial support to continue the research on the COVID-19 vaccine.
The coalition for Epidemic preparedness innovations (CIPI) is a global alliance of India, Norway, the Bill and Melinda Gates foundations, the world economic forum, the UK based Wellcome Trust, the Gavi vaccine alliance also founded by the Gates foundation are harnessing their effort to manufacture, to destitute, and it’s manufacturing in the shortest time possible.
In June 2020 the CEPI, WHO, and Gavi launched COVAX, a global financial, intellectual, and deliberate effort to prepare, distribute, and make sure the availability of COVID-19 vaccine for every patient on the surface of the earth.
The global efforts COVAX to manufacture the vaccine have pledged to spend $18 billion to produce two billion doses of vaccine by the end of the next year, 2021.
By October 2020 about 170 countries had joined the COVAX with the absence of the United States and Russia.
The private sector is spending all available resources to prepare a great COVID-19 vaccine. The pharmaceutical companies, the biotech firms such as Sino pharm, a China-based biotech company, and Johnson & Johnson are harnessing their research on the COVID-19 vaccine. Though there is funding from the government institutions also but the bulk financial support comes from the private institutes.
When we talk about the nonprofit organization the Malinda gates foundation is the flagbearer of the global effort against the COVID-19 and to prepare the vaccines by all means possible in this world.
The research institutes are mainly used for the pre-clinical trials to check the working efficiency of the vaccine. By fortune before the advent of the COVID-19, there were students at Cambridge University who were analyzing the possible vaccine which can prevent future outbreaks and can eradicate them.
Development stages of the COVID-19 Vaccine and its distribution
There is a massive investment in the research and enthusiastic finding of the vaccine which can work to make the patients healthy and can save their lives.
In most cases, there are 6 fundamental stages for the vaccine from preparation to distribution such as;
- Preclinical Preparation
- Clinical Trials
The first and foremost important phase of vaccine production is the research phase. Major institutes such as Harvard, Cambridge, and MIT are forming a coalition to drive a collective research effort to find a perfect cure.
After initial daunting research of the vaccine, there are preclinical trials that ensure that the manufactured vaccine is working or not. If the trials go successful then there is the approval to manufacture the vaccine on a mass scale to help humanity out of this disaster. If people get sick and don’t show a possible improvement in their health the trials go fails and the research again gets started to find something effective.
The distribution phase is the distribution of the vaccine across the globe to all the infected people on the surface of the earth to cure them and to protect the healthy people against this virus.
- How does a COVID-19 vaccine work?
- Who manufactured the COVID-19 Vaccine?
- The vaccine manufactured by the Pfizer/bioNtech company takes 43,500 test trials in six countries with no health concern. After the second dose of the vaccine, the data shows that 90% of the people who got their vaccine show a robust and energetic immune system against the dangers of the COVID-19 virus.
- The pharmaceutical company named AstraZeneca with the collaboration of Oxford University has manufactured the vaccines with astonishing results. The first trial upon the people showed that 70% of the people stop developing COVID-19 symptoms after taking the vaccine. The researches show that a little bit of tinkering with the chemistry of the vaccine will enhance the results of up to 90%.
- The pharmaceutical biotech company modern shows stunning results with the 94.5% recovery of the patient who took the vaccine. The single impetus of the Pfizer/bioNteech pharmaceutical company has generated a ripple effect that will stop after the eradication of the virus from the whole world.
Vaccines are the dead or weakened virus cells known as antigens. They when injected into the body trigger the defensive white blood cells in the immune system to create antibodies against the pathogens. These antibodies create massive action against the viruses and build a wall against them to neutralize them.
There are different types of vaccines which used to create antibodies in one way or the other. When most of the population will be vaccinated against a particular disease then most of the population will be protected against the disease, even at the stake of those who are not immune. This is known as herd immunity when large swamps of the population are safe from the virus.
The United States of America in case of measles, polio, chickenpox, and mumps was able to achieve herd immunity.
In the case of the COVID-19 vaccine, scientists are working to find a vaccine, which can protect the majority of humanity to achieve herd immunity. The estimates are highlighting that to achieve herd immunity the eighty percent of the population of the world has been duly vaccinated.
There was lots of stress upon the world health organization, the leading Malinda Gates organization, and other international collateral COVAX for the manufacturing of the COVID-19 vaccine.
The feat of manufacturing the COVID-19 vaccine was achieved in November by the Pfizer/bioNtech company based in the United States.
There are more companies which are taking random trails of their samples such as;
The United Kingdom (UK) is the first country to get the COVID-19 vaccine
The question to get a vaccine is intriguing, alarming, and concerning. But there’s no point to take any tension. Because it all depends upon the location and the readiness of financial resources of each nation on the surface of the earth.
The United Kingdom has become the first nation to get the vaccine manufactured from the Pfizer and German bioNtech pharmaceutical company.
There were three meticulous trials of the COVID-19 vaccine. In the third trial, the COVID-19 vaccine shows an auspicious result of recovering 95% of the patients of the COVID-19 who were vaccinated. It was a breakthrough in such a short time.
The United Kingdom breaks the nostalgia of making the vaccine for the COVID-19 which has killed around 1.5 million people across the world. This feat places the United Kingdom ahead of the European Union and the United States.
After the vaccine was manufactured in the United Kingdom the biggest challenge for the government was its fair and equal distribution. To tackle this conundrum, they have devised a priority list in which the home residents, elders, and health workers are the first to get treatment of the COVID-19.
The UK after getting the vaccine from Pfizer has ordered the other round 2 billion doses from the AstraZeneca pharmaceutical company.
After the UK the American nation, other European states, and China will be the ones to get the vaccine.
The UK government has prioritized the order for Covid-19 vaccines as...
- Residents in care homes for older adults and their caregivers
- All those 80 years old and over.
Frontline health and social care workers
- All those 75 and over
- All those 70 and over.
Clinically extremely vulnérable individuals
- All those 65 and over
- All individuals aged 16-64 with underlying health conditions which put them at higher risk of serious disease and mortality
- All those 60 and over
- All those 55 and over
- All those 50 and over
There are uncertainties about the vaccine’s effectiveness in curing the victims of the COVID-19. The UNESCO and the WHO are showing grave concerns over the vaccine. There are chances of mutations that can damage the other cells of the immune system.
To take these concerns into considerations that leading health organizations are enforcing the trials and tests to measure the efficacy of the COVID-19 vaccine.
Once the results would show promising results then it’s easy to vaccinate the mass population in the entire globe confidently.
Though there are paramedics staff overseeing the efficacy of the COVID-19 vaccine still the WHO has appointed its medical staff in each country where the vaccine will be distributed to avert the possible side effects of the COVID-19 vaccine.
There are various COVID-19 vaccine conspiracy theories which arise in recent months to halt the vaccination process.
The world is growing at a fast pace more than ever as compared to the past progress of humanity. The glaring technological and infrastructural development gives rise to certain theories.
The 21st century is the a world of wonder where gene editing, cyborg manufacturing, and intense research on human consciousness and brain neurons are underway.
- An article published in the New York Times indicated that there is a specific gene in the human body that enabled the behaviours of billions of people on theist religions to believe in the mastermind of all creations.
This gives rise to the conspiracy theory about the COVID-19 vaccine that it can change the gene or can edit it to change the fundamental principle of billions of people on planet earth to not believe in the Omnipotent GOD.
This has caused the provocation of the religious zealots to libel the true motive of the COVID-19 vaccine and its true motivation to get rid of humanity from the disaster.
- Then we all using the 4G internet technology that is pervasive in the world. But in recent months there was a heavy investment in the development of the 5G internet which can enable the dreams of the virtual world into reality.
Some research studies indicated that the 5G technology can potentially suspend the gas particles in the air and can obstruct their free movement that can make networks of oxygen in different spaces.
The restriction to free movement can cause suffocation and difficulty in inhaling and exhaling the air because of the impediments.
The COVID-19 is all about lung problems, breathing problems and lung infection. This research gives rise to the conspiracy theory that the melodrama of the COVID-19 is an intentional deviation to distract the attention of the masses from the 5G that was launched during the lockdown in the space.
Now after the sustained threat of the COVID-19, the people are believing in the efficacy of the vaccine as the first trial of the Pfizer and the BioNtech company of Germany has gained 90 percent recovery of the victims of the COVID-19.
The confusion and uncertainty beget life loss in the case of the COVID-19. The relentless research and the ceaseless trials of the vaccine are showing a peculiar behaviour of the COVID-19.
The World Health Organization's (WHO) Director-General Tedros Adhanom Ghebreyesus says that the virus is not showing the same behaviour all over the world.
There are strong possibilities coming out from the recent findings that the virus can be tamed with the existing tools that have been provided by the world health organization WHO. The indispensable availability of the vaccine is solely depending upon the region, its environment, the immunity of people, the infrastructural design and health care facilities. WHO’s director-general Tedros Adhanom Ghebreyesus is enforcing on relying on the local tools.
Whenever humanity had achieved a feat there were doubts and unmitigated speculations about the long-lasting effects. The COVID-19 is no exception. After when Pfizer made the first vaccine to confront and eliminate the coronavirus there are now concerns that whether it has the potential to eradicate the virus or not?
After initial trials in the UK by the Pfizer vaccines and the trials by the AstraZeneca pharmaceutical company shows optimistic and encouraging results that had led to another concern that It's now sure that the vaccine has the potential to cure 90% of patients but will all the population get the vaccination?
The group of 20 (G20) has pledged to remove this concern of masses. It has committed to distributing the vaccine across the globe at fair prices with widespread and easy accessibility. There is even now possible that the vaccine can ignite a new type of confrontation on the international forum over the vaccine bidding.
Due to stunning mysterious theories about the coronavirus, some people are even reluctant to get a coronavirus vaccine. A September poll by the pew research institute shows that half of the Americans surveyed said that they wouldn’t take the vaccine if it were present at that time. Though now people are understanding the severity of the situation.
The concerns about the effectiveness of the vaccine will remain until people get the vaccine. In that condition only is the possibility to cure all psychological concerns of the people.
The scientists are saying that uncovering facts about the virus and the effectiveness of the vaccine will further assist us to manufacture a more robust vaccine to eliminate the virus.
Once the world will attain herd immunity as in the case of pervasive coronavirus it has achieved already then there will be no concern about the outbreak.
Until we achieve herd immunity, we have to take care of and follow the guidelines from the CDC and the world health organization diligently.
The promising results of the COVID-19 vaccine and its effectiveness in mitigating the COVID-19 from the victims are ambitious.
The future is not bleak, and but all prospects of the COVID-19 vaccine are not auspicious. What is alarming is the demand.
There is a crucial need for the COVID-19 vaccine all over the world with a safe and reliable supply and large reservoirs of the COVID-19 vaccine.
The proactive and alert staff needed to contain any further outbreak of the COVID-19. The vaccines can cure, can eliminate the virus but the mutation and side effects can also rise. To quell all these problems a cautious and adept staff is necessary to oversee all these developments under the shadow of the COVID-19 vaccine.
To perform all the processes seamlessly and flexibly there is a dire need to supply the nurses and caregiver staff in the hospital to vaccinate the avalanche of people.
Once the WHO and other leading figures will be able to build the trust, the large supply chain, the protective reservoirs of the vaccine, and the open and easy availability to the people then the herd immunity will be achieved to annihilate the COVID-19.
Covid-19 Vaccine Latest News:
Update: 23nd January 2021
Due to the recent global pandemic, COVID-19 Virus, it has become tough to travel between countries. As a result, various business relationships, study courses, official orders and trades are in the line to of getting hampered. Travelling is still possible but a person has to go through a screening process, get a proof of being COVID negative before entering a foreign territory. Even after arriving there, he needs to stay in quarantine for a certain number of days to ensure safety. All these require a huge time and thus the affairs are belated and there occurs a huge loss in the respective fields. To avoid this situation a new system has been enacted which can make this process faster. This is the COVID-19 Vaccination Certificate.
According to the report by SchengenVisaInfo.com, Iceland is the first Schengen country to issue COVID-19 Vaccination Certificates to its citizens who are vaccinated for the second time against the COVID-19 Virus, starting from January 21, 2021. This decision has been announced by the Ministry of Health. The Office of the Medical Director of Health has been working on an electronic platform that lets people get a vaccination certificate online. The Ministry of Health denotes in a press release-
“The aim is to facilitate the movement of people between countries so that individuals can present a vaccine certificate at the border and are then exempt from COVID-19 disease control measures in accordance with the rules of the country concerned.”
A traveller must present his vaccination certificate at the airport. If not, he would have to go through the previously enacted time-consuming process.
It has been also stated that a common vaccine certificate might be introduced among the European Union countries by the EU Commission for the member states to adopt. The statement was made about 10 months ago.
At the beginning of December 2020, Cyprus had also announced that by the coming March, they will allow any person to enter their territory if he/she can show them proof of vaccination, as an addition to the common requirements for a visa.
An announcement has been made such that the Etihad Airways and the International Air Transport Association have partnered and launched a type of travel pass mobile app that lets the passengers easily handle the COVID-19 tests for vaccines and requirements for the travel. The app is named as ‘IATA Travel Pass’. They will be offering Etihad’s guests from some selected flights from Abu Dhabi at the beginning of 2021. They are going to enable the ‘Digital Passport’ system for the guests and the guests will be able to verify their eligibility to travel. All the data regarding the travel and COVID-19 test results and vaccines will be stored in their official database. The passengers will be able to manage their travel through this system throughout their journey.
Update: 19nd January 2021
India hopes to stand first in the world as COVID-19 vaccination drive by vaccinating 300 million people.
All Serbian citizens are expected to be vaccinated by the end of June 2021.
COVID-19 vaccines will be available for every Canadian citizen by September.
By the end of March 2021, all Israeli citizens over the age of 16 will be vaccinated for COVID-19, posing as the world’s first country for inoculating the COVID-19 vaccine announced by Israeli Prime Minister Benjamin Netanyahu.
By the middle of February, 15 million vulnerable people will be offered COVID-19 vaccines and by mid-July, all UK adults could be vaccinated as promised by the UK government.
Update: 02nd January 2021
- Covid vaccine companies Pfizer, Moderna, and AstraZeneca could manufacture 5.3 billion doses by the end of 2021, which will be used to vaccinate 3 billion people (as some vaccines require 2 doses).
Update: 24th December 2020
Canada approves moderna vaccine and will get 1.2 million doses from both Moderna and Pfizer Inc by Jan. 31, 2021.
Mexico: Mexico's military started vaccination on Tuesday; they will be vaciante 125,000 this year.
Update: 23rd December 2020
UK New Coronavirus Variant
When the world was beginning to think that respite might have come finally, with high hope that the COVID-19 pandemic which dominated a good part of the year 2020 would be less brutish in the coming year, thanks to the ongoing vaccine deployment, then news broke.
It is now confirmed that the coronavirus might have mutated. There is now a new strain of Sars-CoV-2 in town. The PHE had released a preliminary report of its findings which confirmed that this particular strain is being more rapidly transmitted than the initial one. They, however, cannot say yet how deadly this new one is, compared to the former.
What makes it different?
This new Sars-Cov-2 is also referred to as (Variant Under Investigation) VUI 202012/01. It was identified by COVID-19 genomics UK (COG-UK). It is an offshoot of multiple mutations of the single RNA Sars-Cov-2 virus. The faster transmission rate is being made possible due to the spike protein found around VUI that binds it to the ACE2 receptor in the human cell.
Cases of the new virus
Other than the UK, several other countries in Europe; Denmark, Netherlands and Australia have corroborated the reports emanating from the UK. Italy and a few more countries have also confirmed that they have recorded cases of this new COVID-19 variant in their countries.
Any link between this new strain and the recent covid-19 vaccine inoculation program?
Neither the WHO nor the Public Health England (PHE) has been able to establish any connection between the recent ongoing vaccination program and the new virus strain. They are rather optimistic that the vaccine already out there will work against the new variant of coronavirus. This is according to Prof Chris Whitty – England’s medical chief.
The resulting precautions by the UK and other countries around the world. Travel restrictions, new lockdown measures
The UK has imposed a new and much tighter restriction in south-east England to avoid large scale spreading of the virus among its populace. During the week also, some other countries around the world announced a temporal closure of their air space and land borders to inbound flight from the UK. A few other countries like India, however, will in the meantime be restricting both inbound and outbound flights connecting them to the United Kingdom.
Lockdown and other measures are being announced by countries, in the wake of this new reality and with the Christmas and New Year festivity around the corner. The World Health Organization (WHO) also earlier in the week said they are in ‘close contact’ with the UK, keeping tabs on the latest development as it concerns this new coronavirus strain.
Update: 22nd December 2020
All Overseas orders for Chinese vaccines about 400 million
Hong Kong 7.5
Chinese all companies show capacity of total production 1.6 billion Covid-19 vaccine, in until the end of 2021.
The EU's approval BioNTech/Pfizer Covid-19vaccine, the vaccinations will start from December 27.
Update: 21st December 2020
China: As per South China Morning Post, Chinese to complete the first 50 million doses by January 15 and the second dose by February 5 with a total 100 Million doses injected.
Madrona: 6 million modern doses, 2 million fizz this week in USA
Israel: The Government of Israel started mass Covid vaccination about 60000 doses / day to inject its people and total 2 million within this month mean 1 million people at the end of the year will be vaccinated.
Update: 19th December 2020
Switzerland: has approved the COVID-19 vaccine from Pfizer and German pharmaceutical company BioNTech.
World: More Than 5 Million People Have been Vaccinated.
US: USA approved Modena vaccine as second Covid-19 vaccine in the United States, about 20million Moderna Covid-19 vaccines will be delivered in this month and about 100m will be before March 30, 2021.
India: is expecting COVID-19 mass vaccination rollout in January 2021, its massive plan to vaccinate the entire population, first in line high-priority groups and age 50 older. Indian officials said the country's 154,000 doctors and 223,000 nurses already run the world's biggest immunisation programme, more than 40 million newborns and pregnant women against 12 diseases every year; So India already does have resources and experience, Now it time to vaccinate 1 billion people. https://www.bbc.com/news/world-asia-india-55314709 https://vaccine.icmr.org.in/covid-19-vaccine
China is preparing for a mass COVID-19 vaccination campaign for 50 million people in high-priority groups ahead of Chinese New Year end of January 2021. Three are 3 COVID-19 vaccines ( Sinovac ) that have emergency approval. source: https://cna.asia
India and China already do have resources and experience of massive vaccination.
China vaccinated over 1 million from July 2020.
Update: 18th December 2020
- United States: 4 Months
- Canada: 6 Months
- United Kingdom: 7 Months
- European Union: 9 Months
"It's Europe's moment. On 27, 28 and 29 December vaccination will start across the EU," von der Leyen tweeted.
Number of months (from December 2020) expected for countries to reach vaccine-based herd immunity. The US, Canada and the UK are expected to be the first because they have secured the most doses.
Vaccination based total pollution herd immunity estimate (excluding natural immunity), based on supply deals in December 2020 made by countries.
AstraZeneca, Pfizer and Moderna estimate that they can make 5.2 billion doses by 2021, which could cover the vaccination needs of around 2.6 billion world’s population.
Vaccine-based herd immunity could be reached by April 2021 in US.
The government is targeting to inoculate 107 million people aged 18 to 59 through two schemes.
Indonesia has deals for more than 250 million doses until the end of 2021
Update: 17th December 2020
Brunei: Brunei is keen with her fight against Covid-19 as they have also joined the Covax scheme. They are projecting that by the end of April 2021 half of its population would have been vaccinated. Beyond the global Covax scheme, Brunei is also in talks with other Covid-19 vaccine suppliers.
Cambodia: Cambodia is looking at procuring COVID-19 vaccines from both China and Russia. The Cambodian government is sticking with the Chinese vaccines even though the vaccines are still undergoing clinical trials. The Russian vaccines on the other hand are already in the production stage. Cambodia is also expected to be a part of the Covid-19 vaccine largesse, in financial support from Australia to Southeast Asia countries.
Indonesia: The vast Asian nation with around 270 million population has started its COVID-19 vaccination with a paltry 9 million doses going to the front line health workers. With a single Sinovac dose going for 200,000 rupiah ($14), the Indonesian government is worried about the cost implication for the massive population. Only people between the ages of 18 and 59 will be vaccinated according to the country’s Disease Control and Prevention boss, General Achmad Yurianto. The COVID-19 vaccine still has one last hurdle before usage – the halal certification. To mitigate the financial implications on the lean purse of the country, Australia is offering some support.
Laos: Laos is in talks with China and also has an eye on Russian’s Sputnik V vaccine in a bid to source vaccinations for its populace.
Malaysia: Malaysia is aggressive with her inoculation program as she intends to provide free vaccines to its nationals, while foreigners will be paying for the vaccine. Against the targeted Q1 of 2021 commencement of the vaccination program, Malaysian health minister, Tan Sri Muhyiddin Yassin has signed a deal with Pfizer for 12.8 million doses for 6.4 million people taking two shots each. Between 80 and 100 percent of the country’s citizens are to be inoculated.
Myanmar: Myanmar, still under US sanctions, is also faced with financial and logistic issues as COVID-19 cases keep increasing. Not all gloomy, as Australia is offering some financial aid. To treat 20 percent of her ‘most at risk’ populace, Myanmar has turned to Gavi and Covax programs for assistance with COVID-19 vaccine procurement. No Christmas and other celebrations in Myanmar this year, according to the government.
Philippines: Vaccination will start in the Philippines from Q2 2021, with 25% of the population (25 million people) expected to take the vaccine before the end of the year. The second most affected country in Southeast Asia will enjoy the benevolence from the corporate world, as 30 local companies only 9 days ago signed an agreement to procure 2.6 million AstraZeneca COVID-19 vaccines. The companies involved will inoculate their staff members while a large chunk of which will be donated to the government to augment the planned vaccination program.
Singapore: The collaboration between US multinational, Arcturus and Singaporean Duke-NUS medical school is birthing Lunar COVID-19 vaccine. A sharp departure from other vaccines which use dead COVID-19 cells, the ‘Lunar’ vaccine is a creation of harmless virus developed from COVID-19 genes that were genetically altered will be a single mRNA shot. This vaccine which is expected by Q1 2021 will go to high risk workers first and other people will follow after, in an order as the government so determines.
Thailand: Thais will have to wait till middle of 2021 before getting their AstraZeneca COVID-19 vaccines. This first delivery worth 2.38 billion baht ($79 million) is expected to cater for a fifth of the 69 million Thailand population (about 13 million people). They are also looking at procuring vaccines from Oxford University if they pass the trial stage in time so as to attend to the inoculation needs of its populace by Q1 of 2021.
Vietnam: There has been an agreement between Vietnam’s National Institute of Hygiene and Epidemiology (NIHE) and a Taiwan-based vaccine company, Medigen Vaccine for the supply of between 3 and 10 million COVID-19 vaccine doses in 2021. Medigen is co-developing the vaccine, which is undergoing stage II trails with the USA’s National Institutes of Health (NIH), in Taiwan and Vietnam. A roll out is expected in Q1 2021.
Vietnam through the Institute of Vaccines and Medical Biologicals (IVAC) is also partnering with Icahn, a New York-based School of Medicine and PATH, a global health non-profit organization, for the production of their own vaccine. The vaccine is currently in phase 1 trial. With their plan to seek the health ministry’s approval as early as April 2021, the second and third phases are to be conducted early 2021. A projected production of 30 million doses per year is being predicted and the government is planning that the general population should be inoculated by October 2021.
Afghanistan: Afghanistan is overwhelmed as it tries to combat two pandemics simultaneously. Hit with Polio and the global COVID-19, Afghanistan has UNICEF to thank for the quick Polio vaccination intervention. For the COVID-19 pandemic, however, they are in talks with both China and Russia for vaccines. The rate of administering treatment for both among the populace has been excessively slow due to the lockdowns imposed by the government at the wake of renewed Taliban conflict, and the lack of awareness of the disease.
Bangladesh: When vaccination commences in Q1 2021, Bangladesh will ensure inoculation of at least 20 percent of its populace from the 68 million COVID-19 vaccine doses expected from Gavi. Steps to procure additional 30 million doses from India’s Serum Institute are also ongoing. Each complete dose goes for 450 Taka ($5) per complete dose while Gavi dose costs about 200 Taka ($2). The country is also in discussions with India concerning a further 30 million doses from the Serum Institute at about 450 Taka (US$5).
Bahrain: COVID-19 vaccinations for front line personnel have commenced in Bahrain. They are using Sinopharm, a joint Chinese-UAE product. The general of Bahrains can have the shot by Q1 2021.
East Timor: To combat the ravaging COVID-19, East Timor is partnering with Gavi Institute for some assistance.
Hong Kong: Hong Kong expects that by the end of 2021 all citizens and residents would have been vaccinated, and that free of charge. The inoculation will be in stages.
India: India is looking at a massive roll out of multiple vaccines round the year 2021. By January-February 2021, India expects that AstraZeneca’s Covishield and Biotech’s Covaxin from Oxford and Bharat respectively will be available for emergency usage. Covishield’s emergency approval is being awaited while Covaxin’s is estimated to be approved for emergency by early February. India expects four other vaccines to augment the first two by the end of Q1 2021. The Indian government is targeting that vaccines be given to 300 targeted Indians by July 2021.
Iran: Iran’s COVID-19 vaccine is in the trial stage. This is a product of a partnership with Russia to produce. Iran is working to kick start a national inoculation program by September 2021.
Iraq: Iraq is waiting on US based company, Pfizer for its COVID-19 supplies expected by Q2 2021.
Japan: As from Q1 2021, Japan’s free inoculation program will commence. 145 million COVID-19 vaccine doses are being sourced by the Japanese government from the United States and the UK.
Jordan: Pfizer will be supplying Jordan vaccines for its inoculation program that is to commence from Q1 2021.
Update: 16th December 2020
Chilean:The health officials on Wednesday approved the use of Pfizer's vaccine against Covid-19, the second country in Latin America to approve it.
Update: 15th December 2020
India: India’s guidelines for mass vaccination drive is that the government is planning to vaccinate approx 30 cr people along with healthcare & frontline workers, people above 50 years of age, those under 50 with comorbidities.
Update: 14th December 2020
Canada: Canada starers Covid-19 vaccination at 14 distribution sites across the country first shot happen in Toronto at University Health Network, a plan up to 249,000 doses to be vaccinate in Canada by the end of the year 2020.
US: The US beginning of the end of Pandemic, started Covid-19 Pfizer vaccine rollout, The first 3 million doses distribution to all 50 states @ 150 facilities and another 485 facilities will get in next 2 days.
As the Bill Gates said- The pandemic ends in the next 4-6 months and there could be 200000 deaths with covid-19.
Certainly by 4-6 months we will get rid of this covid-19 virus and we have a chance to get back to normal lives.
Singapore approved Pfizer-BioNTech's Covid-19 vaccine.
Russia: Covid-19 Vaccine Sputnik-V, developed by Russia's Gamaleya Research Institute of Epidemiology was the first Covid-19 vaccine to get emergency use authorisation at 11 August in Russia.
China: China approve Sinovac Biotech's Covid-19 vaccine for emergency use in July 2020.
Update: 13th December 2020
United States: Made the 5th country to approve Pfizer vaccine for coronavirus in America after FDA approved under emergency use authorisation for people 16 and older, this happened on the same day as US recorded record high death and case of coronavirus US, as decision made after consideration of benefits over risk based on scientific data.
Pfizer headquarters started at the moment with the UPS and others to supply vaccines to hospitals overnight.The mass vaccination could be starting on this Monday morning, with a new hope of sunshine.
Update: 12th December 2020
Argentina: President Alberto Fernandez on Thursday says the country has purchased Russia's Sputnik V coronavirus vaccine for 10 million people. With over 40,000 Covid-19 deaths and 1.5 million infections in the South American country, the country is relying on the 95% effective Sputnik vaccine to stem the tide of Covid-19.
President Fernandez also said to dispel fears, he would be the first person to have the shot once the National Administration of Drugs, Food and Medical Technology approves the vaccine. A targeted 300,000 people are estimated to be vaccinated before the end of the year with the first shipment of 600,000 doses.
The country will take delivery of another set of doses for 5 million people in January before getting the remainder for 4.4 million people in February.
Update: 11th December 2020
USA: The Trump administration said 20 million Doses of covid-19 vaccine will be vaccinated to US people by December 31, 2020. One company is testing out Drones as a possible solution to distribution of vaccines.
FDA’s COVID-19 advisory panel voted 17-4 to approve Pfizer-BioNTech vaccine. President Elect Biden promises distribution of 100 million shots in 100 days after taking office.
Canada: 96,000 Doses by December 31, 2020 of Pfizer vaccine.
UK: NHS are proud to compare their achievement at rolling out the Meningitis C vaccination nationwide in 1999 to the current nationwide COVID-19 vaccination ongoing.
Argentina: President Says He’ll Get Russia Vaccine To Dispel Fears
Update: 10th December 2020
UK: About 6.7 million people judged to be the highest priority, Residents in care homes and over 80 years; so that requires 13.4 million doses. A total 6.7 million highest priority people could be vaccinated by the end of Jan 2021.
USA: Advisory panel meet on Thursday, may recommend approval of Pfizer-BioNTech COVID-19 vaccine by FDA. Pfizer-BioNTech announced that there was a cyberattack on EMA leading to theft of their COVID-19 vaccine development documents
The United Arab Emirates (UAE) granted full approval to the Sinopharm Beijing Institute of Biological Covid-19 vaccine on 9 December and Bahrain it on 10 december. The china media reported, Sinopharm already had vaccine Covid-19 pre-orders from more than 102 countries as Sinopharm could produce billions of doses in 1st quarter of 2021. United Arab Emirates state Sinopharm conducte trial over 125 nationalities people and announced within two weeks the whole country will be on full resume like before.
Update: 9th December 2020
Canadian approved Pfizer and BioNTech vaccine, and will receive up to 249,000 doses by end of Dec, 2020 and 4 million more in 2021.
The UK Government announced People with “significant allergic reactions” should not currently receive the Pfizer vaccine after 2 people had allergic reactions who had been vaccinated on Tuesday.
USA coronavirus cases crossed the 15 million mark as regulators moved closer to approving the COVID-19 vaccine.
The UAE officially third-phase trials analysis, Chinese Sinopharm Covid-19 vaccine is 86% effective.
India: India's Ministry of Health has announced that some COVID-19 vaccines are likely to be approved and licensed within the next few weeks and outline a preliminary plan to vaccinate 300 million people.
Israel: Israel received its first batch of Pfizer’s coronavirus vaccine, This is a great celebration for Israel “The end is in sight,” Netanyahu said referring to the disease which has infected 348,948 Israelis, 2,932 of them fatally, according to a Wednesday update.
Update: 8th December 2020
- In the United Kingdom (UK) the first dose of the Pfizer/BioNtech COVID-19 vaccination has been started.
Update: 7th December 2020
Indonesia has received its first consignment of coronavirus (Covid-19) vaccine from China with a dose of over one million, Also another expected to be shipped 1.8 million next month.
Canada will get up to 249,000 doses of Pfizer Inc’s COVID-19 vaccine before the end of December, assuming it is approved by the health ministry, the government said.
Update: 6th December 2020
United state: US biotech firm Moderna, is awaiting approval in various countries, including the US. The company expects to have 20 million doses available in the US by December 2020 and 1 billion in 2021.
The US Government has purchased 650,000 additional doses of Eli Lilly and Co neutralising antibody bamlanivimab (LY-CoV555) for $812.5 million. The doses will be delivered through 31 January, with at least 350,000 delivered in December, the company said.
New York expects to receive 170,000 doses of Pfizer Inc.’s vaccine on December 15,
Update: 5th December 2020
Russia: Russia has already vaccinated more than 100,000 high-risk people, Health Minister Mikhail Murashko said earlier this week during a separate presentation to the United Nations about Sputnik V.
And 2 million Covid-19 vaccination additional people end of 2020
Turkey: Turkey bought the Covid-19 vaccine from Chinese company Sinovac about 50 million shots within Jan 2021.
Turkey already received 1 million shots of the CoronaVac in the second shipment of the vaccine. The first shipment of 120,000 shots arrived from China on November 19.
Brazil: Brazil is importing 46 million doses of China’s Sinovac vaccine against COVID-19 Nov 2020.
Covas said 10,000 volunteers had already received about 19,000 shots of the two-dose vaccine, and 2,000 other people had still to be included in the trials.
India: Bharat Biotech’s Covaxin Covid-19 vaccine candidate, has started Phase III human clinical trials at the All India Institute of Medical Sciences in New Delhi. Around 15,000 volunteers will be enrolled into the trial in the next few days reports suggested.
China: China currently has five coronavirus vaccine candidates, 4 companies already reached phase 3 clinical trials in at least 16 countries.
China Sinovac Biotech Covid-19 vaccine will be provided 46 million doses to Brazil and 50 million doses to Turkey. It'll also supply 40 million doses ( vaccine bulk concentrate ) to Indonesia. will deliver 35 million doses of its vaccine to Mexico.
China National Biotec Group (CNBG)- Sinopharm two vaccines in phase 3 trials in 10 countries, ( Sinopharm two vaccines in phase 3 trials in 10 countries, (Middle East and South America). In the United Arab Emirates to get 75 and 100 million doses next year.). In the United Arab Emirates to get 75 and 100 million doses next year.
Covid-19 vaccines made in China will be accessible to African countries, Cambodia, Myanmar, Laos, Thailand, Vietnam, Afghanistan and Malaysia.
Sinopharm coronavirus vaccine given to 1 million people in tails.
Chinese vaccine has been given to about 56,000 people ( Chinese construction workers, diplomats, and students ) who have gone to more than 150 countries around the world during the pandemic until November 6, 2020.
Sinopharm had carried out Phase 3 clinical trials involving almost 60,000 people in 10 countries -- including the UAE, Bahrain, Egypt, Jordan, Peru, and Argentina. CNN has not seen the results of these trials yet.
- China Global Television Network formerly CCTV International;
- https://www.who.int/, https://www.nbcnews.com/us-news
The coronavirus COVID-19, Cases. Received and Deaths around the world.